NRF2 and the Hallmarks of Cancer.

[1]  G. DeNicola,et al.  The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism. , 2017, Antioxidants & redox signaling.

[2]  Donna D. Zhang,et al.  The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer , 2018, Molecular carcinogenesis.

[3]  Agustin Sola-Carvajal,et al.  Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome. , 2017, Biochemical Society transactions.

[4]  John Calvin Reed,et al.  Therapeutics targeting Bcl-2 in hematological malignancies. , 2017, The Biochemical journal.

[5]  B. Stockwell,et al.  Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.

[6]  Francisco J. Sánchez-Rivera,et al.  Keap1 loss promotes Kras-driven lung cancer and results in a dependence on glutaminolysis , 2017, Nature Medicine.

[7]  Aikseng Ooi,et al.  The Roles of NRF2 in Modulating Cellular Iron Homeostasis , 2017, Antioxidants & redox signaling.

[8]  A. Monteiro,et al.  The Role of PALB2 in the DNA Damage Response and Cancer Predisposition , 2017, International journal of molecular sciences.

[9]  C. Hagedorn,et al.  Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture , 2017, Scientific Reports.

[10]  M. Rauh,et al.  Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis , 2017, Oncogenesis.

[11]  A. Nicolas,et al.  The impact of replication stress on replication dynamics and DNA damage in vertebrate cells , 2017, Nature Reviews Genetics.

[12]  T. Honda,et al.  Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses , 2017, Oncogene.

[13]  Ash A. Alizadeh,et al.  Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. , 2017, Cancer discovery.

[14]  S. Rankin,et al.  Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders , 2017, Journal of clinical medicine.

[15]  A. Dinkova-Kostova,et al.  Regulation of the mammalian heat shock factor 1 , 2017, The FEBS journal.

[16]  S. Sampattavanich,et al.  Nrf2 in keratinocytes modulates UVB-induced DNA damage and apoptosis in melanocytes through MAPK signaling , 2017, Free radical biology & medicine.

[17]  E. White,et al.  Autophagy and Tumor Metabolism. , 2017, Cell metabolism.

[18]  Shuyi Zhang,et al.  ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway , 2017, Molecular Cancer.

[19]  R. Toth,et al.  Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia , 2017, Antioxidants.

[20]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[21]  Cynthia M. Cipolla,et al.  Peroxisomal Dysfunction in Age-Related Diseases , 2017, Trends in Endocrinology & Metabolism.

[22]  E. Ho,et al.  Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2‐independent mechanism , 2017, Aging cell.

[23]  A. I. Rojo,et al.  Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease , 2017, Scientific Reports.

[24]  Hong Zhang,et al.  Suppression of radiation-induced migration of non-small cell lung cancer through inhibition of Nrf2-Notch Axis , 2017, Oncotarget.

[25]  John G Doench,et al.  KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer , 2017, eLife.

[26]  P. Liu,et al.  p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex , 2017, Molecular and Cellular Biology.

[27]  Sushobhan Biswas,et al.  Ferulic acid (FA) abrogates γ-radiation induced oxidative stress and DNA damage by up-regulating nuclear translocation of Nrf2 and activation of NHEJ pathway , 2017, Free radical research.

[28]  D. Walerych,et al.  Mutant p53–Nrf2 axis regulates the proteasome machinery in cancer , 2017, Molecular & cellular oncology.

[29]  H. Yao,et al.  Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis , 2016, Scientific Reports.

[30]  Hae-June Lee,et al.  NQO1 inhibits proteasome-mediated degradation of HIF-1α , 2016, Nature Communications.

[31]  Han-dong Wang,et al.  Interplay between VEGF and Nrf2 regulates angiogenesis due to intracranial venous hypertension , 2016, Scientific Reports.

[32]  Lei Wang,et al.  NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction , 2016, Oncotarget.

[33]  T. Hawley,et al.  Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming , 2016, Oncotarget.

[34]  T. Guilarte,et al.  In Vitro Effects of Lead on Gene Expression in Neural Stem Cells and Associations between Up-regulated Genes and Cognitive Scores in Children , 2016, Environmental health perspectives.

[35]  A. Ferrando,et al.  Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1. , 2016, Cancer research.

[36]  Brandon Da Silva,et al.  NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer , 2016, Cell.

[37]  Chi V. Dang,et al.  From Krebs to clinic: glutamine metabolism to cancer therapy , 2016, Nature Reviews Cancer.

[38]  V. Thongboonkerd,et al.  Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells , 2016, Scientific Reports.

[39]  A. Ciechanover,et al.  The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death , 2016, Cell Research.

[40]  M. L. de Ceballos,et al.  Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes , 2016, Autophagy.

[41]  A. Sundan,et al.  Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells , 2016, Blood Cancer Journal.

[42]  Shujiro Okuda,et al.  p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming , 2016, Nature Communications.

[43]  A. Rosato,et al.  Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer , 2016, Nature Cell Biology.

[44]  M. Nitti,et al.  Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy , 2016, Oxidative medicine and cellular longevity.

[45]  R. Laskowski,et al.  Rising levels of atmospheric oxygen and evolution of Nrf2 , 2016, Scientific Reports.

[46]  T. Misteli,et al.  Repression of the Antioxidant NRF2 Pathway in Premature Aging , 2016, Cell.

[47]  H. Guillou,et al.  Novel Grb14-Mediated Cross Talk between Insulin and p62/Nrf2 Pathways Regulates Liver Lipogenesis and Selective Insulin Resistance , 2016, Molecular and Cellular Biology.

[48]  K. Nakayama,et al.  Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription , 2016, Nature Communications.

[49]  A. Kraft,et al.  PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species , 2016, Molecular Cancer Therapeutics.

[50]  T. Shibata,et al.  NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth. , 2016, Cancer research.

[51]  O. Harismendy,et al.  Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance. , 2016, Cell reports.

[52]  Xiaocui Wang,et al.  NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis , 2016, Science Translational Medicine.

[53]  Christian M. Metallo,et al.  Reductive carboxylation supports redox homeostasis during anchorage-independent growth , 2016, Nature.

[54]  Yuyuan Dai,et al.  Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma , 2016, Cellular and Molecular Neurobiology.

[55]  Hyung-Ryong Kim,et al.  Endoplasmic Reticulum Stress and Associated ROS , 2016, International journal of molecular sciences.

[56]  K. Okoń,et al.  Preliminary Analysis of the Expression of Selected Proangiogenic and Antioxidant Genes and MicroRNAs in Patients with Non-Muscle-Invasive Bladder Cancer , 2016, Journal of clinical medicine.

[57]  Yoorim Choi,et al.  Cellular localization of NRF2 determines the self-renewal and osteogenic differentiation potential of human MSCs via the P53–SIRT1 axis , 2016, Cell Death and Disease.

[58]  T. Kensler,et al.  Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane. , 2016, Seminars in oncology.

[59]  D. Tang,et al.  Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells , 2016, Hepatology.

[60]  Hongting Zheng,et al.  An Essential Role of NRF2 in Diabetic Wound Healing , 2015, Diabetes.

[61]  Linehan Wm,et al.  Blockage of cisplatin-induced autophagy sensitizes cervical cancer cells to cisplatin. , 2015 .

[62]  Abdel Kareem Azab,et al.  The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy , 2015, Hypoxia.

[63]  Donna D. Zhang,et al.  Systemic administration of the apocarotenoid bixin protects skin against solar UV-induced damage through activation of NRF2. , 2015, Free radical biology & medicine.

[64]  A. Azmi,et al.  Immune evasion in cancer: Mechanistic basis and therapeutic strategies. , 2015, Seminars in cancer biology.

[65]  In-geun Ryoo,et al.  Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance , 2015, Oxidative medicine and cellular longevity.

[66]  J. Lang,et al.  Oxidative stress, mammospheres and Nrf2–new implication for breast cancer therapy? , 2015, Molecular carcinogenesis.

[67]  H. Motohashi,et al.  Roles of Nrf2 in cell proliferation and differentiation. , 2015, Free radical biology & medicine.

[68]  A. Dinkova-Kostova,et al.  The emerging role of Nrf2 in mitochondrial function , 2015, Free radical biology & medicine.

[69]  H. Milnerowicz,et al.  The influence of oxidative stress induced by iron on telomere length. , 2015, Environmental toxicology and pharmacology.

[70]  Jun Chen,et al.  Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes. , 2015, Oncology reports.

[71]  M. Freeman,et al.  Nrf2 promotes survival following exposure to ionizing radiation. , 2015, Free radical biology & medicine.

[72]  J. Hayes,et al.  Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. , 2015, Free radical biology & medicine.

[73]  Donna D. Zhang,et al.  p62 links autophagy and Nrf2 signaling. , 2015, Free radical biology & medicine.

[74]  R. Orlowski,et al.  The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma* , 2015, The Journal of Biological Chemistry.

[75]  Chih-Yi Chen,et al.  Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2 , 2015, Oncotarget.

[76]  R. Deberardinis,et al.  NRF2 regulates serine biosynthesis in non-small cell lung cancer , 2015, Nature Genetics.

[77]  Donna D. Zhang,et al.  A Curcumin Derivative That Inhibits Vinyl Carbamate-Induced Lung Carcinogenesis via Activation of the Nrf2 Protective Response. , 2015, Antioxidants & redox signaling.

[78]  Debojyoti Pal,et al.  Nrf2 facilitates repair of radiation induced DNA damage through homologous recombination repair pathway in a ROS independent manner in cancer cells. , 2015, Mutation research.

[79]  Donna D. Zhang,et al.  Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention , 2015, Biochemical Society transactions.

[80]  B. Sipos,et al.  The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells , 2015, PloS one.

[81]  Mingxin Zhang,et al.  Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma , 2015, BMC Cancer.

[82]  Xiuli Zhang,et al.  Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1. , 2015, Molecular medicine reports.

[83]  R. Brandes,et al.  Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability. , 2015, Free radical biology & medicine.

[84]  T. Soussi,et al.  TP53: an oncogene in disguise , 2015, Cell Death and Differentiation.

[85]  Seamus J. Martin,et al.  Autophagy in malignant transformation and cancer progression , 2015, The EMBO journal.

[86]  T. Arnould,et al.  Mitochondria: a target for bacteria. , 2015, Biochemical pharmacology.

[87]  S. Ibbotson,et al.  Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans , 2015, Cancer Prevention Research.

[88]  K. Itoh,et al.  Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria , 2015, Journal of clinical biochemistry and nutrition.

[89]  Z. Storchová,et al.  Aneuploidy and proteotoxic stress in cancer , 2015, Molecular & cellular oncology.

[90]  In-geun Ryoo,et al.  Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells , 2015, Oncotarget.

[91]  Donna D. Zhang,et al.  Nrf2-Dependent Suppression of Azoxymethane/Dextran Sulfate Sodium–Induced Colon Carcinogenesis by the Cinnamon-Derived Dietary Factor Cinnamaldehyde , 2015, Cancer Prevention Research.

[92]  Daniel E. Johnson.  The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors. , 2015, Endocrine-related cancer.

[93]  P. Rada,et al.  The PTEN/NRF2 axis promotes human carcinogenesis. , 2014, Antioxidants & redox signaling.

[94]  L. Gordon,et al.  Sulforaphane enhances progerin clearance in Hutchinson–Gilford progeria fibroblasts , 2014, Aging cell.

[95]  Donna D. Zhang,et al.  Oncogenic KRAS confers chemoresistance by upregulating NRF2. , 2014, Cancer research.

[96]  Jiri Bartek,et al.  Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress , 2014, Molecular oncology.

[97]  Timothy E. O’Sullivan,et al.  Tumor-expressed IL-17D recruits NK cells to reject tumors , 2014, Oncoimmunology.

[98]  P. Schumacker,et al.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.

[99]  Hyung-Seok Kim,et al.  Nrf2, a Regulator of the Proteasome, Controls Self‐Renewal and Pluripotency in Human Embryonic Stem Cells , 2014, Stem cells.

[100]  Elgene Lim,et al.  PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair. , 2014, Cancer discovery.

[101]  Han-dong Wang,et al.  Knockdown of nuclear factor erythroid 2-related factor 2 by lentivirus induces differentiation of glioma stem-like cells. , 2014, Oncology reports.

[102]  J. Wang,et al.  Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment. , 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[103]  H. Jaeschke,et al.  Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy. , 2014, Journal of hepatology.

[104]  R. Kaufman,et al.  The impact of the endoplasmic reticulum protein-folding environment on cancer development , 2014, Nature Reviews Cancer.

[105]  Lin Zhu,et al.  Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia‐induced activation of HIF‐1α , 2014, International journal of cancer.

[106]  S. Werner,et al.  Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell‐cycle control and apoptosis , 2014, Hepatology.

[107]  J. Hayes,et al.  Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance , 2014, Molecular and Cellular Biology.

[108]  Soo-Wan Chae,et al.  Endoplasmic Reticulum Stress and Cancer , 2014, Journal of cancer prevention.

[109]  T. Shimosegawa,et al.  Myeloid Lineage–Specific Deletion of Antioxidant System Enhances Tumor Metastasis , 2014, Cancer Prevention Research.

[110]  T. Finkel,et al.  Cellular mechanisms and physiological consequences of redox-dependent signalling , 2014, Nature Reviews Molecular Cell Biology.

[111]  H. Ikeda,et al.  Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. , 2014, Cell reports.

[112]  O. Hammarsten,et al.  Repeated Nrf2 stimulation using sulforaphane protects fibroblasts from ionizing radiation. , 2014, Toxicology and applied pharmacology.

[113]  Chang S. Chan,et al.  Autophagy is required for glucose homeostasis and lung tumor maintenance. , 2014, Cancer discovery.

[114]  C. Porta,et al.  Targeting PI3K/Akt/mTOR Signaling in Cancer , 2014, Front. Oncol..

[115]  P. Duerksen-Hughes,et al.  Human Papillomavirus Type 16 E6* Induces Oxidative Stress and DNA Damage , 2014, Journal of Virology.

[116]  T. Nakajima,et al.  Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis , 2014, Genes & development.

[117]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[118]  V. Gorgoulis,et al.  Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation , 2014, Cell Death and Differentiation.

[119]  C. Kenific,et al.  Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. , 2014, Cancer discovery.

[120]  Ying Zhang,et al.  Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. , 2014, The Biochemical journal.

[121]  Donna D. Zhang,et al.  Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription. , 2014, Free radical biology & medicine.

[122]  I. Trougakos,et al.  Molecular chaperones and proteostasis regulation during redox imbalance☆ , 2014, Redox biology.

[123]  Stéphanie Panier,et al.  Double-strand break repair: 53BP1 comes into focus , 2013, Nature Reviews Molecular Cell Biology.

[124]  S. Biswal,et al.  Notch-Nrf2 Axis: Regulation of Nrf2 Gene Expression and Cytoprotection by Notch Signaling , 2013, Molecular and Cellular Biology.

[125]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[126]  E. White,et al.  Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. , 2013, Cancer discovery.

[127]  A. Schulze,et al.  Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development , 2013, Disease Models & Mechanisms.

[128]  V. Gorgoulis,et al.  Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis. , 2013, Journal of proteomics.

[129]  Donna D. Zhang,et al.  The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV , 2013, Redox biology.

[130]  Donna D. Zhang,et al.  The emerging role of the Nrf2–Keap1 signaling pathway in cancer , 2013, Genes & development.

[131]  Donna D. Zhang,et al.  The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death , 2013, Autophagy.

[132]  H. Cao,et al.  O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas , 2013, Cell Death and Disease.

[133]  Xia Li,et al.  Integration of Autophagy and Anoikis Resistance in Solid Tumors , 2013, Anatomical record.

[134]  H. Schreiber,et al.  Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.

[135]  H. Saibil.  Chaperone machines for protein folding, unfolding and disaggregation , 2013, Nature Reviews Molecular Cell Biology.

[136]  T. Mizushima,et al.  Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. , 2013, Molecular cell.

[137]  Lisong Shen,et al.  Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production , 2013, Cell Death and Disease.

[138]  Lin Zhu,et al.  The role of Nrf2 in migration and invasion of human glioma cell U251. , 2013, World neurosurgery.

[139]  D. Llères,et al.  Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex , 2013, Proceedings of the National Academy of Sciences.

[140]  E. White,et al.  Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRASG12D-driven lung tumors , 2013, Autophagy.

[141]  Lin Zhu,et al.  Nrf2 is required to maintain the self-renewal of glioma stem cells , 2013, BMC Cancer.

[142]  S. Inoue,et al.  BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival , 2013, The Journal of experimental medicine.

[143]  T. Jacks,et al.  Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. , 2013, Genes & development.

[144]  Kwok-Kin Wong,et al.  Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. , 2013, The Journal of clinical investigation.

[145]  Masayuki Yamamoto,et al.  Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. , 2013, Cancer research.

[146]  V. Carraro,et al.  The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression , 2013, Nucleic acids research.

[147]  E. Heiss,et al.  Glucose availability is a decisive factor for Nrf2-mediated gene expression☆ , 2013, Redox biology.

[148]  Masayuki Yamamoto,et al.  Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration , 2013, Biology Open.

[149]  M. Lisanti,et al.  Inhibition of nuclear factor-erythroid 2–related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence , 2013, Molecular biology of the cell.

[150]  A. Sugawara,et al.  The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus , 2013, Molecular and Cellular Biology.

[151]  H. Bhat,et al.  Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer , 2013, BMC Cancer.

[152]  M. O. Landázuri,et al.  The transcription factor Nrf2 promotes survival by enhancing the expression of uncoupling protein 3 under conditions of oxidative stress. , 2013, Free radical biology & medicine.

[153]  E. White,et al.  Arsenic Inhibits Autophagic Flux, Activating the Nrf2-Keap1 Pathway in a p62-Dependent Manner , 2013, Molecular and Cellular Biology.

[154]  S. Niture,et al.  Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance. , 2013, Free radical biology & medicine.

[155]  C. Klaassen,et al.  Genetic Activation of Nrf2 Protects against Fasting-Induced Oxidative Stress in Livers of Mice , 2013, PloS one.

[156]  T. Haystead,et al.  Hsp90, an unlikely ally in the war on cancer , 2013, The FEBS journal.

[157]  Pier Paolo Pandolfi,et al.  Cancer metabolism: fatty acid oxidation in the limelight , 2013, Nature Reviews Cancer.

[158]  Shang Li,et al.  The role of telomere biology in cancer. , 2013, Annual review of pathology.

[159]  A. Levonen,et al.  The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer☆ , 2013, Redox biology.

[160]  Q. Ma.  Role of nrf2 in oxidative stress and toxicity. , 2013, Annual review of pharmacology and toxicology.

[161]  C. Yabe-Nishimura,et al.  ROS‐generating oxidases Nox1 and Nox4 contribute to oncogenic Ras‐induced premature senescence , 2013, Genes to cells : devoted to molecular & cellular mechanisms.

[162]  Donna D. Zhang,et al.  Does Nrf2 contribute to p53-mediated control of cell survival and death? , 2012, Antioxidants & redox signaling.

[163]  K. Itoh,et al.  Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers , 2012, Oncogene.

[164]  C. Piantadosi,et al.  Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. , 2012, Free radical biology & medicine.

[165]  T. Pandita,et al.  Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation , 2012, Proceedings of the National Academy of Sciences.

[166]  J. Manautou,et al.  Nrf2: A Potential Target for New Therapeutics in Liver Disease , 2012, Clinical pharmacology and therapeutics.

[167]  A. Cuadrado,et al.  Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. , 2012, Oncogene.

[168]  Mingxin Zhang,et al.  Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2 , 2012, Journal of experimental & clinical cancer research : CR.

[169]  H. Aburatani,et al.  Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.

[170]  P. Rada,et al.  Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis , 2012, Molecular and Cellular Biology.

[171]  Mitchell R. McGill,et al.  Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[172]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[173]  Michelle R. Campbell,et al.  Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha , 2012, Nucleic acids research.

[174]  G. Wondrak,et al.  Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes. , 2012, Biochemical pharmacology.

[175]  A. Choi,et al.  Caveolin-1 Inhibits Expression of Antioxidant Enzymes through Direct Interaction with Nuclear Erythroid 2 p45-related Factor-2 (Nrf2)* , 2012, The Journal of Biological Chemistry.

[176]  E. White.  Deconvoluting the context-dependent role for autophagy in cancer , 2012, Nature Reviews Cancer.

[177]  S. Singh,et al.  Acetyl‐L‐carnitine‐mediated neuroprotection during hypoxia is attributed to ERK1/2‐Nrf2‐regulated mitochondrial biosynthesis , 2012, Hippocampus.

[178]  Paul J Thornalley,et al.  Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. , 2012, The Biochemical journal.

[179]  D. Butterfield,et al.  Oxidative Stress in HPV-Driven Viral Carcinogenesis: Redox Proteomics Analysis of HPV-16 Dysplastic and Neoplastic Tissues , 2012, PloS one.

[180]  B. Sobhian,et al.  PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function , 2012, Molecular and Cellular Biology.

[181]  Patrick G. Shaw,et al.  Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles , 2012, Breast Cancer Research and Treatment.

[182]  S. Niture,et al.  Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis* , 2012, The Journal of Biological Chemistry.

[183]  S. Powell,et al.  BRCA1 and BRCA2: different roles in a common pathway of genome protection , 2011, Nature Reviews Cancer.

[184]  Tsonwin Hai,et al.  ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression , 2011, Nature Medicine.

[185]  L. Chung,et al.  Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells , 2011, Molecular Cancer Research.

[186]  J. Fostel,et al.  Targeted Deletion of Nrf2 Reduces Urethane-Induced Lung Tumor Development in Mice , 2011, PloS one.

[187]  C. Klaassen,et al.  Beneficial role of Nrf2 in regulating NADPH generation and consumption. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[188]  Won Dong Kim,et al.  Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding. , 2011, Antioxidants & redox signaling.

[189]  Do-Hee Kim,et al.  Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in PC12 cells. , 2011, Nitric oxide : biology and chemistry.

[190]  T. Finkel,et al.  Signal transduction by reactive oxygen species , 2011, The Journal of cell biology.

[191]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[192]  E. White,et al.  Role of Autophagy in Cancer Prevention , 2011, Cancer Prevention Research.

[193]  A. Brandl,et al.  Oxidative stress induces senescence in chondrocytes , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[194]  L. Sistonen,et al.  Regulation of HSF1 function in the heat stress response: implications in aging and disease. , 2011, Annual review of biochemistry.

[195]  Keiji Tanaka,et al.  Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells , 2011, The Journal of cell biology.

[196]  Y. Eishi,et al.  Autophagy-deficient mice develop multiple liver tumors. , 2011, Genes & development.

[197]  Fiona Campbell,et al.  Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy , 2011, Molecular Cancer.

[198]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[199]  C. Piantadosi,et al.  Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression* , 2011, The Journal of Biological Chemistry.

[200]  M. Kwak,et al.  Transcription factor Nrf2 maintains the basal expression of Mdm2: An implication of the regulation of p53 signaling by Nrf2. , 2011, Archives of biochemistry and biophysics.

[201]  M. Kwak,et al.  NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. , 2011, Cancer research.

[202]  Limin Liu,et al.  Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine , 2011, Carcinogenesis.

[203]  M. Ohmura,et al.  CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. , 2011, Cancer cell.

[204]  Christina M. Birch,et al.  KPNA6 (Importin α7)-Mediated Nuclear Import of Keap1 Represses the Nrf2-Dependent Antioxidant Response , 2011, Molecular and Cellular Biology.

[205]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[206]  E. Mercken,et al.  Genetic deletion of Nrf2 promotes immortalization and decreases life span of murine embryonic fibroblasts. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[207]  H. Coller,et al.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. , 2011, Genes & development.

[208]  C. Carlberg,et al.  Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism* , 2011, Journal of Biological Chemistry.

[209]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[210]  L. Crawford,et al.  Proteasome inhibitors in cancer therapy , 2011, Journal of Cell Communication and Signaling.

[211]  P. Rada,et al.  SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner , 2011, Molecular and Cellular Biology.

[212]  S. Hirohashi,et al.  Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway. , 2010, Cancer research.

[213]  Guido Kroemer,et al.  Autophagy and the integrated stress response. , 2010, Molecular cell.

[214]  M. McMahon,et al.  Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals , 2010, Proceedings of the National Academy of Sciences.

[215]  V. Raman,et al.  Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. , 2010, Carcinogenesis.

[216]  T. Standiford,et al.  Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury. , 2010, American journal of respiratory and critical care medicine.

[217]  M. Kwak,et al.  Regulation of Notch1 Signaling by Nrf2: Implications for Tissue Regeneration , 2010, Science Signaling.

[218]  Biswal,et al.  NADPH Oxidase-Dependent Reactive Oxygen Species Mediate Amplified TLR4 Signaling and Sepsis-Induced Mortality in Nrf2-Deficient Mice , 2010, The Journal of Immunology.

[219]  Masayuki Yamamoto,et al.  Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver , 2010, Journal of proteomics.

[220]  A. Cuadrado,et al.  Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2/Trx axis. , 2010, Free radical biology & medicine.

[221]  David J. Arenillas,et al.  Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis , 2010, Nucleic acids research.

[222]  E. White,et al.  A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62 , 2010, Molecular and Cellular Biology.

[223]  L. Coussens,et al.  Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity , 2010, Cancer and Metastasis Reviews.

[224]  M. Komatsu,et al.  Physiological significance of selective degradation of p62 by autophagy , 2010, FEBS letters.

[225]  DelindaA . Johnson,et al.  The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[226]  Mihee M. Kim,et al.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 , 2010, Nature Cell Biology.

[227]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[228]  Laura Leung,et al.  Deficiency in the Nuclear Factor E2-related Factor-2 Transcription Factor Results in Impaired Adipogenesis and Protects against Diet-induced Obesity* , 2010, The Journal of Biological Chemistry.

[229]  N. Chondrogianni,et al.  Nuclear Erythroid Factor 2-mediated Proteasome Activation Delays Senescence in Human Fibroblasts* , 2010, The Journal of Biological Chemistry.

[230]  J. Hampe,et al.  Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2) , 2009, Oncogene.

[231]  G. Wondrak.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities. , 2009, Antioxidants & redox signaling.

[232]  Donna D. Zhang,et al.  Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels , 2009, Cell cycle.

[233]  M. Sporn,et al.  Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. , 2009, European journal of pharmacology.

[234]  A. Ciechanover,et al.  The 26 S Proteasome: From Basic Mechanisms to Drug Targeting* , 2009, The Journal of Biological Chemistry.

[235]  D. McConkey,et al.  Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells , 2009, Oncogene.

[236]  M. McMahon,et al.  Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. , 2009, Carcinogenesis.

[237]  J. Turchi,et al.  Molecular analysis of Ku redox regulation , 2009, BMC Molecular Biology.

[238]  Donna D. Zhang,et al.  Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. , 2009, Molecular cell.

[239]  Gyan Bhanot,et al.  Autophagy Suppresses Tumorigenesis through Elimination of p62 , 2009, Cell.

[240]  M. Sporn,et al.  Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. , 2009, Carcinogenesis.

[241]  N. Kikuchi,et al.  Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer , 2009, Clinical Cancer Research.

[242]  E. Rosen,et al.  BRCA1 down‐regulates cellular levels of reactive oxygen species , 2009, FEBS letters.

[243]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[244]  S. Lindquist,et al.  Inhibiting the transcription factor HSF1 as an anticancer strategy , 2009 .

[245]  M. Gonsebatt,et al.  The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. , 2009, Mutation research.

[246]  Kenta Iwasaki,et al.  Role of the tumor suppressor PTEN in antioxidant responsive element-mediated transcription and associated histone modifications. , 2009, Molecular biology of the cell.

[247]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[248]  Y. Nasuhara,et al.  Down-regulated Nf-e2–related Factor 2 in Pulmonary Macrophages of Aged Smokers and Patients with Chronic Obstructive Pulmonary Disease Materials and Methods Collection of Human Alveolar Macrophages , 2022 .

[249]  K. Macleod.  The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system , 2008, Nature Reviews Cancer.

[250]  K. Itoh,et al.  Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements. , 2008, Archives of biochemistry and biophysics.

[251]  Peng Huang,et al.  Redox regulation of cell survival. , 2008, Antioxidants & redox signaling.

[252]  M. Ono.  Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy , 2008, Cancer science.

[253]  M. Day,et al.  The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis , 2008, Oncogene.

[254]  Weimin Chen,et al.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. , 2008, Carcinogenesis.

[255]  C. Klaassen,et al.  NF-E2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet , 2008, Journal of Pharmacology and Experimental Therapeutics.

[256]  A. I. Rojo,et al.  GSK‐3β down‐regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress , 2008 .

[257]  Thomas Helleday,et al.  DNA repair pathways as targets for cancer therapy , 2008, Nature Reviews Cancer.

[258]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[259]  J. Debnath,et al.  Induction of autophagy during extracellular matrix detachment promotes cell survival. , 2007, Molecular biology of the cell.

[260]  G. Wondrak,et al.  Experimental therapeutics: targeting the redox Achilles heel of cancer. , 2007, Current opinion in investigational drugs.

[261]  S. Orkin,et al.  Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. , 2007, Genes & development.

[262]  S. Biswal,et al.  NRF2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on Adipogenesis , 2007, Molecular and Cellular Biology.

[263]  Hye-Min Jeon,et al.  Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species–mediated damage , 2007, Molecular Cancer Therapeutics.

[264]  P. Chiarugi,et al.  Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. , 2007, Cancer research.

[265]  Donna D. Zhang,et al.  Keap1 Controls Postinduction Repression of the Nrf2-Mediated Antioxidant Response by Escorting Nuclear Export of Nrf2 , 2007, Molecular and Cellular Biology.

[266]  K. Gupta,et al.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer , 2007, Nature Medicine.

[267]  V. O'shea,et al.  Base-excision repair of oxidative DNA damage , 2007, Nature.

[268]  G. Wondrak.  Let the sun shine in: mechanisms and potential for therapeutics in skin photodamage. , 2007, Current opinion in investigational drugs.

[269]  M. Smyth,et al.  Immune surveillance of tumors. , 2007, The Journal of clinical investigation.

[270]  H. Pelicano,et al.  Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. , 2007, Cancer research.

[271]  G. Yen,et al.  Differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway , 2007, Biogerontology.

[272]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[273]  T. Russo,et al.  p53 Suppresses the Nrf2-dependent Transcription of Antioxidant Response Genes* , 2006, Journal of Biological Chemistry.

[274]  H. Rabb,et al.  Reoxygenation‐specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia‐reperfusion injury , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[275]  C Roland Wolf,et al.  Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents. , 2006, Cancer research.

[276]  S. Biswal,et al.  Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. , 2006, Archives of biochemistry and biophysics.

[277]  Akira Kobayashi,et al.  Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism , 2006, Biological chemistry.

[278]  J. Herman,et al.  Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer , 2006, PLoS medicine.

[279]  K. Itoh,et al.  Dimerization of Substrate Adaptors Can Facilitate Cullin-mediated Ubiquitylation of Proteins by a “Tethering” Mechanism , 2006, Journal of Biological Chemistry.

[280]  A. Conney,et al.  Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. , 2006, Cancer research.

[281]  Paul J Thornalley,et al.  Increased Dicarbonyl Metabolism in Endothelial Cells in Hyperglycemia Induces Anoikis and Impairs Angiogenesis by RGD and GFOGER Motif Modification , 2006, Diabetes.

[282]  A. I. Rojo,et al.  Glycogen Synthase Kinase-3β Inhibits the Xenobiotic and Antioxidant Cell Response by Direct Phosphorylation and Nuclear Exclusion of the Transcription Factor Nrf2* , 2006, Journal of Biological Chemistry.

[283]  J. Turchi,et al.  Kinetic Analysis of the Ku-DNA Binding Activity Reveals a Redox-dependent Alteration in Protein Structure That Stimulates Dissociation of the Ku-DNA Complex* , 2006, Journal of Biological Chemistry.

[284]  Jonathan Weissman,et al.  Molecular Chaperones and Protein Quality Control , 2006, Cell.

[285]  P. Bugnon,et al.  Nrf Transcription Factors in Keratinocytes Are Essential for Skin Tumor Prevention but Not for Wound Healing , 2006, Molecular and Cellular Biology.

[286]  Masayuki Yamamoto,et al.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. , 2006, The Journal of clinical investigation.

[287]  R. Tuder.  Faculty Opinions recommendation of Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. , 2006 .

[288]  Tsutomu Ohta,et al.  Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. , 2006, Molecular cell.

[289]  J. Diehl,et al.  Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. , 2006, The international journal of biochemistry & cell biology.

[290]  Paolo Serafini,et al.  Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. , 2006, Seminars in cancer biology.

[291]  K. Itoh,et al.  Nrf2‐deficient mice are highly susceptible to cigarette smoke‐induced emphysema , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[292]  Timothy H Murphy,et al.  Induction of the Nrf2-driven Antioxidant Response Confers Neuroprotection during Mitochondrial Stress in Vivo* , 2005, Journal of Biological Chemistry.

[293]  Gerald Batist,et al.  Transcriptional Regulation of NF-E2 p45-related Factor (NRF2) Expression by the Aryl Hydrocarbon Receptor-Xenobiotic Response Element Signaling Pathway , 2005, Journal of Biological Chemistry.

[294]  K. Itoh,et al.  Ultraviolet A irradiation induces NF-E2-related factor 2 activation in dermal fibroblasts: protective role in UVA-induced apoptosis. , 2005, The Journal of investigative dermatology.

[295]  A. Kong,et al.  Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.

[296]  N. Chondrogianni,et al.  Overexpression of Proteasome β5 Assembled Subunit Increases the Amount of Proteasome and Confers Ameliorated Response to Oxidative Stress and Higher Survival Rates*[boxs] , 2005, Journal of Biological Chemistry.

[297]  R. Kaufman,et al.  ER stress and the unfolded protein response. , 2005, Mutation research.

[298]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[299]  E. Rosen,et al.  BRCA1 Induces Antioxidant Gene Expression and Resistance to Oxidative Stress , 2004, Cancer Research.

[300]  Cun-Yu Wang,et al.  Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma Cells , 2004, Molecular and Cellular Biology.

[301]  E. Kohn,et al.  Anoikis: Cancer and the homeless cell , 2004, Nature.

[302]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[303]  Ken Itoh,et al.  Redox-regulated Turnover of Nrf2 Is Determined by at Least Two Separate Protein Domains, the Redox-sensitive Neh2 Degron and the Redox-insensitive Neh6 Degron* , 2004, Journal of Biological Chemistry.

[304]  R. Morimoto,et al.  Molecular chaperones and the stress of oncogenesis , 2004, Oncogene.

[305]  T. Hagen,et al.  Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[306]  D. Gabrilovich,et al.  Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species1 , 2004, The Journal of Immunology.

[307]  K. Itoh,et al.  Transcription Factor Nrf2 Regulates Inflammation by Mediating the Effect of 15-Deoxy-Δ12,14-Prostaglandin J2 , 2004, Molecular and Cellular Biology.

[308]  Satoru Takahashi,et al.  Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glutathione levels , 2003, Oncogene.

[309]  M. Kwak,et al.  Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway , 2003, Molecular and Cellular Biology.

[310]  Mark Hannink,et al.  Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress , 2003, Molecular and Cellular Biology.

[311]  K. Itoh,et al.  Expression of the aflatoxin B1-8,9-epoxide-metabolizing murine glutathione S-transferase A3 subunit is regulated by the Nrf2 transcription factor through an antioxidant response element. , 2003, Molecular pharmacology.

[312]  B. Friguet,et al.  Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts , 2003, Journal of Biological Chemistry.

[313]  M. Evans,et al.  Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[314]  Ken Itoh,et al.  Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway , 2003, The Journal of Biological Chemistry.

[315]  R. Paules,et al.  An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.

[316]  P. Einat,et al.  Nrf2 is an inhibitor of the Fas pathway as identified by Achilles' Heel Method, a new function-based approach to gene identification in human cells , 2003, Oncogene.

[317]  S. Biswal,et al.  Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. , 2002, Cancer research.

[318]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[319]  Jiang Li,et al.  Microarray Analysis Reveals an Antioxidant Responsive Element-driven Gene Set Involved in Conferring Protection from an Oxidative Stress-induced Apoptosis in IMR-32 Cells* , 2002, The Journal of Biological Chemistry.

[320]  W. E. Fahl,et al.  Functional characterization of transcription regulators that interact with the electrophile response element. , 2001, Biochemical and biophysical research communications.

[321]  A. Choi,et al.  Identification of Activating Transcription Factor 4 (ATF4) as an Nrf2-interacting Protein , 2001, The Journal of Biological Chemistry.

[322]  M. Kwak,et al.  Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[323]  M. Kwak,et al.  Role of Transcription Factor Nrf2 in the Induction of Hepatic Phase 2 and Antioxidative Enzymes in vivo by the Cancer Chemoprotective Agent, 3H-1, 2-Dithiole-3-thione , 2001 .

[324]  J. Yodoi,et al.  Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. , 2000, Cancer research.

[325]  J. Radicella,et al.  Characterization of the hOGG1 promoter and its expression during the cell cycle. , 2000, Mutation research.

[326]  N. Chandel,et al.  Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia , 2000, The Journal of Biological Chemistry.

[327]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[328]  K. Mori,et al.  AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[329]  P. Talalay,et al.  Chemical and molecular regulation of enzymes that detoxify carcinogens. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[330]  A. Dinkova-Kostova,et al.  Transcription factors Hsf1 and Nrf2 engage in crosstalk for cytoprotection. , 2015, Trends in pharmacological sciences.

[331]  W. M. Lin,et al.  Blockage of cisplatin-induced autophagy sensitizes cervical cancer cells to cisplatin. , 2015, Genetics and molecular research : GMR.

[332]  C. Kahn,et al.  Insulin receptor signaling in normal and insulin-resistant states. , 2014, Cold Spring Harbor perspectives in biology.

[333]  Lin Zhu,et al.  Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells , 2013, Journal of Neuro-Oncology.

[334]  B. Bauvois,et al.  New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. , 2012, Biochimica et biophysica acta.

[335]  H. Bhat,et al.  Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer. , 2012, Carcinogenesis.

[336]  M. Serrano,et al.  Senescence in tumours: evidence from mice and humans , 2010, Nature Reviews Cancer.

[337]  C. Klaassen,et al.  Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[338]  S. Linder,et al.  Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA , 2007, International journal of cancer.

[339]  M. Kwak,et al.  Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway IDENTIFICATION OF NOVEL GENE CLUSTERS FOR CELL SURVIVAL* , 2003 .

[340]  Yoichi Taya,et al.  Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.

[341]  Giulia Piaggio,et al.  Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis , 2002, Nature Cell Biology.

[342]  M. Kwak,et al.  Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. , 2001, Molecular medicine.

[343]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.